Myrian® XP Prostate, the new reference tool for worldwide prostate experts.
Elonav, a brand-new application dedicated to specifical needs of neurosurgeons.
Presentation of 3 innovative products based on Myrian® technology.
Strong growth, reaching operating balance.
suspension of the automatic drawdowns of bounds convertible into shares (« OCA »), initially planned in the contract signed on August 27, 2018.
Companies announce today the signing of a pluriannual partnership and distribution agreement
Award ceremony at RSNA 2018 congress
Companies announce the strengthening of their multi-year partnership
Launching of innovative solutions at RSNA 2018 congress
Discussions relating to the scope of the transferred activities and the terms of the combination did not lead to a satisfactory conclusion.
Select your choice...Receive newsGet in touch with the investor serviceOther
By ticking this box, I agree to my data being used by Intrasense to respond to my request and to receive appropriate communications or information. I may withdraw my consent at any time by writing to the Data Protection Officer at dpo@intrasense.fr. For further information, please consult our Privacy Policy.
Please leave this field empty.
En cochant cette case, j'accepte que mes données soient utilisées par Intrasense pour répondre à ma demande et recevoir des communications ou des informations appropriées. Je peux retirer mon consentement à tout moment en écrivant au Délégué à la protection des données à dpo@intrasense.fr. Pour en savoir plus, consultez notre Politique de Confidentialité.
